| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |